{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T12:21:10Z","timestamp":1780834870377,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.tox.2025.154223","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T19:15:36Z","timestamp":1750446936000},"page":"154223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Transcriptomic dose response assessment of PFAS chemicals 3:3 fluorotelomer carboxylic acid, 7:3 fluorotelomer alcohol, and perfluorohexanesulfonamide"],"prefix":"10.1016","volume":"517","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6125-4045","authenticated-orcid":false,"given":"Esra","family":"Mutlu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1529-2387","authenticated-orcid":false,"given":"Leah","family":"Wehmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5393-5677","authenticated-orcid":false,"given":"Alison H.","family":"Harrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1258-4894","authenticated-orcid":false,"given":"Michael","family":"Devito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2340-0301","authenticated-orcid":false,"given":"Russell S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8424-6651","authenticated-orcid":false,"given":"Denise","family":"Macmillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4014-8002","authenticated-orcid":false,"given":"Jackson","family":"Bounds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6392-7784","authenticated-orcid":false,"given":"Chelsea A.","family":"Weitekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9713-6099","authenticated-orcid":false,"given":"Logan J.","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2025.154223_bib1","series-title":"Research Triangle Park (NC): National Institutes of Health (NIEHS)","article-title":"NIEHS report on the in vivo repeat dose biological potency study of perfluorohexanesulfonamide (CASRN 41997-13-1) in Sprague Dawley (Hsd:Sprague Dawley((r)) SD((r))) rats (gavage studies): Niehs report 10","author":"Auerbach","year":"2023"},{"key":"10.1016\/j.tox.2025.154223_bib2","unstructured":"BOSC, 2023. Report of the U.S. Environmental Protection Agency Board of Scientific Counselors EPA Transcriptomic Assessment Product (ETAP) panel. 2023. US EPA BOSC Executive Committee. \u3008https:\/\/www.epa.gov\/system\/files\/documents\/2024-03\/final-bosc-report-etap-epa-response_31924.pdf\u3009."},{"key":"10.1016\/j.tox.2025.154223_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2025.120916","article-title":"Per- and polyfluoroalkyl substances (PFAS) exposure in the U.S. population: NHANES 1999-March 2020","volume":"270","author":"Botelho","year":"2025","journal-title":"Environ. Res."},{"issue":"10","key":"10.1016\/j.tox.2025.154223_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205388","article-title":"Application of benchmark analysis for mixed contaminant exposures: mutual adjustment of perfluoroalkylate substances associated with immunotoxicity","volume":"13","author":"Budtz-Jorgensen","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.tox.2025.154223_bib5","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1289\/ehp.10598","article-title":"Polyfluoroalkyl chemicals in the U.S. population: data from the national health and nutrition examination survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000","volume":"115","author":"Calafat","year":"2007","journal-title":"Environ. Health Perspect."},{"issue":"9","key":"10.1016\/j.tox.2025.154223_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/toxics12090672","article-title":"In vitro hepatic clearance evaluations of per- and polyfluoroalkyl substances (PFAS) across multiple structural categories","volume":"12","author":"Crizer","year":"2024","journal-title":"Toxics"},{"key":"10.1016\/j.tox.2025.154223_bib7","series-title":"Toxicological effects of perfluoroalkyl and polyfluoroalkyl substances","author":"DeWitt","year":"2015"},{"key":"10.1016\/j.tox.2025.154223_bib8","series-title":"IRIS toxicological review of perfluorobutanoic acid (PFBA) and related salts","year":"2022"},{"key":"10.1016\/j.tox.2025.154223_bib9","series-title":"IRIS toxicological review of perfluorohexanoic acid (PFHxA) and related salts","year":"2023"},{"key":"10.1016\/j.tox.2025.154223_bib10","series-title":"Standard methods for development of EPA transcriptomic assessment products (ETAPS)","year":"2024"},{"key":"10.1016\/j.tox.2025.154223_bib11","series-title":"IRIS toxicological review of perfluorodecanoic acid (PFDA) and related salts","year":"2024"},{"key":"10.1016\/j.tox.2025.154223_bib12","series-title":"Value of information case study on the human health and economic trade-offs associated with the timeliness, uncertainty, and costs of the draft EPA transcriptomic assessment product (ETAP)","year":"2024"},{"key":"10.1016\/j.tox.2025.154223_bib13","series-title":"Toxicological review of perfluorohexanesulfonic acid (PFHXS) and related salts: Final report, 2025","year":"2025"},{"key":"10.1016\/j.tox.2025.154223_bib14","unstructured":"EPA, 2024a. Scientific studies supporting development of transcriptomic points of departure for epa\u00a0transcriptomic assessment products (etaps). Washington (DC). No. EPA\/600\/X-23\/084."},{"issue":"3","key":"10.1016\/j.tox.2025.154223_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/etc.4890","article-title":"Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research","volume":"40","author":"Fenton","year":"2020","journal-title":"Environ. Toxicol. Chem."},{"issue":"4","key":"10.1016\/j.tox.2025.154223_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.2011.2034","article-title":"Serum vaccine antibody concentrations in children exposed to perfluorinated compounds","volume":"307","author":"Grandjean","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.tox.2025.154223_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/toxsci\/kfab009","article-title":"High-throughput transcriptomics platform for screening environmental chemicals","volume":"181","author":"Harrill","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154223_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105020","article-title":"Progress towards an OECD reporting framework for transcriptomics and metabolomics in regulatory toxicology","volume":"125","author":"Harrill","year":"2021","journal-title":"Regul. Toxicol. Pharm."},{"issue":"4","key":"10.1016\/j.tox.2025.154223_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/toxics12040271","article-title":"A comparison of in vitro points of departure with human blood levels for per- and polyfluoroalkyl substances (PFAS)","volume":"12","author":"Judson","year":"2024","journal-title":"Toxics"},{"issue":"4","key":"10.1016\/j.tox.2025.154223_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.tox.2025.154223_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"16","key":"10.1016\/j.tox.2025.154223_bib22","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tox.2025.154223_bib23","series-title":"Guide for the care and use of laboratory animals","year":"2011"},{"key":"10.1016\/j.tox.2025.154223_bib24","volume":"NTP-RR-5.","year":"2018"},{"key":"10.1016\/j.tox.2025.154223_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2022.100250","article-title":"Towards reproducible structure-based chemical categories for PFAS to inform and evaluate toxicity and toxicokinetic testing","volume":"24","author":"Patlewicz","year":"2022","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.tox.2025.154223_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.comtox.2022.100258","article-title":"Towards systematic read-across using Generalised Read-Across (GenRA)","volume":"25","author":"Patlewicz","year":"2023","journal-title":"Comput. Toxicol."},{"issue":"10","key":"10.1016\/j.tox.2025.154223_bib27","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/bioinformatics\/bty878","article-title":"BMDExpress 2: enhanced transcriptomic dose-response analysis workflow","volume":"35","author":"Phillips","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tox.2025.154223_bib28","series-title":"EPA Transcriptomic Assessment Product (ETAP) for perfluoro-3-methoxypropanoic acid","author":"Thomas","year":"2024"},{"key":"10.1016\/j.tox.2025.154223_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/1471-2164-8-387","article-title":"BMDExpress: a software tool for the benchmark dose analyses of genomic data","volume":"8","author":"Yang","year":"2007","journal-title":"BMC Genom."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X25001829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X25001829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T05:11:37Z","timestamp":1760591497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X25001829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":29,"alternative-id":["S0300483X25001829"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2025.154223","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptomic dose response assessment of PFAS chemicals 3:3 fluorotelomer carboxylic acid, 7:3 fluorotelomer alcohol, and perfluorohexanesulfonamide","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2025.154223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"154223"}}